ライフサイエンスコーパス: bronchogenic carcinoma

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 scriminate between lung diseases, especially bronchogenic carcinoma.

2 (P < 0.05) lower in NBECs from subjects with bronchogenic carcinoma.

3 raphy, and brain CT or MR imaging in staging bronchogenic carcinoma.

4 to be useful in the diagnosis and staging of bronchogenic carcinoma.

5 number of the malignant lesions were primary bronchogenic carcinoma.

6 patients undergoing resectional surgery for bronchogenic carcinoma.

7 dentify the 5-10% of individuals at risk for bronchogenic carcinoma.

8 primary NBECs from subjects with or without bronchogenic carcinoma.

9 were papillary carcinoma of the thyroid (1), bronchogenic carcinoma (1), inflamed epidermal cyst (1),

10 Of 360 individuals determined to have bronchogenic carcinoma, 50 of 81 (62%) with small cell c

11 phase, exhaled breath of 14 individuals with bronchogenic carcinoma and 45 healthy control subjects o

12 NBECs derived from eight individuals without bronchogenic carcinoma and incubated under identical con

13 ause cellular damage, leading to asbestosis, bronchogenic carcinoma, and mesothelioma in humans.

14 This included seven (26%) patients with bronchogenic carcinoma as a second primary carcinoma.

15 l needle aspiration (TBNA) in the staging of bronchogenic carcinoma (CA), and to assess the predictor

16 ctin mRNA) in NBECs from 23 subjects without bronchogenic carcinoma compared to those from 11 subject

17 Bronchogenic carcinoma develops in the native lung of tr

18 (38%) had lung carcinoma (10 [27%], primary bronchogenic carcinoma; four [11%], carcinoid).

19 likely to have a solitary metastasis than a bronchogenic carcinoma (ratio, 23:9).

20 l were obtained on all patients with primary bronchogenic carcinoma registered in the metropolitan De

21 noma compared to those from 11 subjects with bronchogenic carcinoma respectively (in parentheses) wer

22 at (a) interindividual variation in risk for bronchogenic carcinoma results in part from interindivid

23 d specificity (76%) for detecting NBECs from bronchogenic carcinoma subjects that was better than any

24 will better identify individuals at risk for bronchogenic carcinoma than individual gene expression v

25 or stomach were more likely to have primary bronchogenic carcinoma than lung metastasis (ratio, 25:3

26 20 months, 100 patients with newly diagnosed bronchogenic carcinoma underwent whole-body FDG PET and

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。